Metabolic effects of thyroid hormone derivatives.

The processes and pathways mediating the intermediary metabolism of carbohydrates, lipids, and proteins are all affected by thyroid hormones (THs) in almost all tissues. Particular attention has been devoted by scientists to the effects of THs on lipid metabolism. Among others, effects related to cholesterol, lipid handling, and cardiac performance have been the subject of study. Many reports are present in the literature concerning the calorigenic effect of THs, with most of them aimed at identifying the molecular basis of this effect. However, at the moment the mechanism(s) underlying the metabolic effects of THs remain to be elucidated. THs exert most of their effects though TH receptors (TRs). However, some effects of THs cannot be explained by a nuclear-mediated pathway, and recently an increasing number of nonnuclear actions have been described, which can provide a regulatory system of which the effects differ from those mediated on the transcriptional level by TRs. Some of the TH derivatives (naturally occurring metabolites and analogs) possess biological activities. TH-related biological effects have been described for physiological products such as tetraiodothyroacetic acid (Tetrac) and triiodothyroacetic acid (Triac) (via oxidative deamination and decarboxylation of thyroxine [T4] and triiodothyronine [T3] alanine chain), 3,3',5'-triiodothyronine (rT3) (via T4 and T3 deiodination), 3,3'-diiodothyronine (3,3'-T2) and 3,5-diiodothyronine (T2) (via T4, T3, and rT3 deiodination), and 3-iodothyronamine (T1AM) and thyronamine (T0AM) (via T4 and T3 deiodination and amino acid decarboxylation), as well as for TH structural analogs, such as 3,5,3'-triiodothyropropionic acid (Triprop), 3,5-dibromo-3-pyridazinone-l-thyronine (L-940901), N-[3,5-dimethyl-4-(4'-hydroxy-3'-isopropylphenoxy)-phenyl]-oxamic acid (CGS 23425), 3,5-dimethyl-4[(4'-hydroxy-3'-isopropylbenzyl)-phenoxy] acetic acid (GC-1), 3,5-dichloro-4[(4-hydroxy-3-isopropylphenoxy)phenyl] acetic acid (KB-141), and 3,5-diiodothyropropionic acid (DITPA). Most of these compounds have interesting properties: counteracting lipid accumulation, reducing cholesterol level, and increasing lipid metabolism without cardiotoxic effects. Hopefully, further studies on basic mechanisms of such compounds will be harbingers of more knowledge on the metabolic effects of TH derivatives and on their possible clinical application.

[1]  L. Ye,et al.  Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. , 2003, Journal of medicinal chemistry.

[2]  S. Leoni,et al.  Short-term effects of thyroid hormones and 3,5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. , 2002, Endocrinology.

[3]  J. C. Emmett,et al.  A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity , 1986, Nature.

[4]  A. Burger,et al.  The nondeiodinative pathways of thyroxine metabolism: 3,5,3',5-tetraiodothyroacetic acid turnover in normal and fasting human subjects. , 1980, The Journal of clinical endocrinology and metabolism.

[5]  G. Brent,et al.  Spared bone mass in rats treated with thyroid hormone receptor TR beta-selective compound GC-1. , 2003, American journal of physiology. Endocrinology and metabolism.

[6]  B. Kadenbach,et al.  A second mechanism of respiratory control , 1999, FEBS letters.

[7]  F. B. Davis,et al.  The Proangiogenic Action of Thyroid Hormone Analogue GC-1 Is Initiated at an Integrin , 2005, Journal of cardiovascular pharmacology.

[8]  M. Surks,et al.  Specific nuclear triiodothyronine binding sites in rat liver and kidney. , 1972, The Journal of clinical endocrinology and metabolism.

[9]  J. Ballantyne,et al.  Direct effects of 3,5,3'-triiodothyronine and 3,5-diiodothyronine on mitochondrial metabolism in the goldfish Carassius auratus. , 1996, General and comparative endocrinology.

[10]  T. Scanlan,et al.  Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. , 2007, The Journal of endocrinology.

[11]  B. Gloss,et al.  The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity. , 2000, Endocrinology.

[12]  Johan Malm,et al.  Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Tata,et al.  Control of Basal Metabolic Rate by Thyroid Hormones and Cellular Function , 1962, Nature.

[14]  C. Martius,et al.  The mode of action of thyroxin. , 1951, Archives of biochemistry and biophysics.

[15]  D. Grandy,et al.  Novel Thyroxine Derivatives, Thyronamine and 3-iodothyronamine, Induce Transient Hypothermia and Marked Neuroprotection Against Stroke Injury , 2007, Stroke.

[16]  Bernhard Kadenbach,et al.  Intrinsic and extrinsic uncoupling of oxidative phosphorylation. , 2003, Biochimica et biophysica acta.

[17]  S. Goldman,et al.  Pilot Studies on the Use of 3,5-Diiodothyropropionic Acid, a Thyroid Hormone Analog, in the Treatment of Congestive Heart Failure , 2002, Cardiology.

[18]  R. W. Rawson,et al.  COMPARATIVE EFFECTS OF THYROXINE ANALOGUES IN EXPERIMENTAL ANIMALS * , 1960, Annals of the New York Academy of Sciences.

[19]  F. Goglia,et al.  In vitro binding of triiodothyronine to rat liver mitochondria , 1981, Pflügers Archiv.

[20]  P. Ladenson,et al.  Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects. , 1992, The Journal of clinical endocrinology and metabolism.

[21]  A. Engle,et al.  Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine. , 1995, Journal of medicinal chemistry.

[22]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[23]  G. Stoltenburg‐Didinger,et al.  3,3'-Diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors and of healthy subjects during acute stress. , 1998, The Journal of clinical endocrinology and metabolism.

[24]  A. Lombardi,et al.  Are the effects of T3 on resting metabolic rate in euthyroid rats entirely caused by T3 itself? , 2002, Endocrinology.

[25]  J. Tata,et al.  Inhibition of the Biological Action of Thyroid Hormones by Actinomycin D and Puromycin , 1963, Nature.

[26]  V. Skulachev,et al.  Biological effects of 3,5-diiodothyronine (T2) , 2005, Biochemistry (Moscow).

[27]  N. Wong,et al.  Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism , 1997 .

[28]  T. Visser,et al.  Biochemical mechanisms of thyroid hormone deiodination. , 2005, Thyroid : official journal of the American Thyroid Association.

[29]  Hung-Yun Lin,et al.  Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. , 2005, Endocrinology.

[30]  J. Kvetny 3,5-T2 Stimulates Oxygen Consumption, But Not Glucose Uptake in Human Mononuclear Blood Cells , 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[31]  W Craelius,et al.  Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. , 1999, Journal of molecular and cellular cardiology.

[32]  A. Hulbert,et al.  Thyroid hormones and their effects: a new perspective , 2000, Biological reviews of the Cambridge Philosophical Society.

[33]  H. Samuels,et al.  Thyroid hormone action in cell culture: domonstration of nuclear receptors in intact cells and isolated nuclei. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Dratman On the mechanism of action of thyroxin, an amino acid analog of tyrosine. , 1974, Journal of theoretical biology.

[35]  M. Brand,et al.  Effect of 3,5-di-iodo-L-thyronine on the mitochondrial energy-transduction apparatus. , 1998, The Biochemical journal.

[36]  M. Krotkiewski Thyroid hormones in the pathogenesis and treatment of obesity. , 2002, European journal of pharmacology.

[37]  D. Williams,et al.  3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance. , 1989, The Journal of clinical endocrinology and metabolism.

[38]  E. Gerdoni,et al.  3,5-diiodothyronine Mimics the Effect of Triiodothyronine on Insulin-like Growth Factor Binding Protein-4 Expression in Cultured Rat Hepatocytes , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[39]  F. Goglia,et al.  3,5-Diiodothyronine binds to subunit Va of cytochrome-c oxidase and abolishes the allosteric inhibition of respiration by ATP. , 1998, European journal of biochemistry.

[40]  E. Jéquier,et al.  Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine. , 1993, The Journal of clinical endocrinology and metabolism.

[41]  A. Lombardi,et al.  3,5-Diiodo-l-thyronine and 3,5,3′-triiodo-l-thyronine both improve the cold tolerance of hypothyroid rats, but possibly via different mechanisms , 1998, Pflügers Archiv.

[42]  F. Goglia,et al.  Action of thyroid hormones at the cellular level: the mitochondrial target , 1999, FEBS letters.

[43]  J. Baxter,et al.  A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. , 1998, Chemistry & biology.

[44]  Alessandro Antonelli,et al.  3,5‐Diiodo‐L‐thyronine powerfully reduces adiposity in rats by increasing the burning of fats , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  M. Zimmerman,et al.  A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. , 1998, Journal of molecular and cellular cardiology.

[46]  R. Fletterick,et al.  Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies. , 1998, Recent progress in hormone research.

[47]  A. Orozco,et al.  Effects of iodothyronines on the hepatic outer-ring deiodinating pathway in killifish. , 2004, General and comparative endocrinology.

[48]  A. Pietrzykowski,et al.  Dynamic nongenomic actions of thyroid hormone in the developing rat brain. , 2006, Endocrinology.

[49]  G. Gnoni,et al.  Short-term stimulation of lipogenesis by 3,5-L-diiodothyronine in cultured rat hepatocytes. , 2005, Endocrinology.

[50]  J. C. Emmett,et al.  Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart. , 1988, Journal of medicinal chemistry.

[51]  S. Soboll,et al.  Rapid stimulation of calcium uptake into rat liver by L-tri-iodothyronine. , 1989, The Biochemical journal.

[52]  R. Evans,et al.  The c-erb-A gene encodes a thyroid hormone receptor , 1986, Nature.

[53]  H. Jarry,et al.  3,5-Diiodo-l-Thyronine Stimulates Type 1 5'Deiodinase Activity in Rat Anterior Pituitaries in Vivo and in Reaggregate Cultures and GH3 Cells in Vitro. , 1997, Endocrinology.

[54]  S. Ball,et al.  3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro. , 1997, Journal of molecular endocrinology.

[55]  M. Safran,et al.  Structural requirements of iodothyronines for the rapid inactivation and internalization of type II iodothyronine 5'-deiodinase in glial cells. , 1993, The Journal of biological chemistry.

[56]  D. Tibboel,et al.  Characterization of iodothyronine sulfatase activities in human and rat liver and placenta. , 2002, Endocrinology.

[57]  H. Rokos,et al.  Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-L-thyronine. , 1989, The Biochemical journal.

[58]  A. Lombardi,et al.  Control of energy metabolism by iodothyronines , 2001, Journal of endocrinological investigation.

[59]  A. Lombardi,et al.  Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-l-thyronine and by 3,3′-diiodo-l-thyronine , 1994, Molecular and Cellular Endocrinology.

[60]  G. Grover,et al.  Selective thyroid hormone agonists: A strategy for treating metabolic syndrome , 2005 .

[61]  D. Grandy,et al.  Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. , 2006, Journal of medicinal chemistry.

[62]  S. Leoni,et al.  Short-term effects of thyroid hormone in prenatal development and cell differentiation , 2005, Steroids.

[63]  F. Goglia,et al.  In vitro binding of 3,5-di-iodo-L-thyronine to rat liver mitochondria. , 1994, Journal of molecular endocrinology.

[64]  O. Oommen,et al.  Short-term effects of thyroid hormones on lipogenic enzymes and 14C-acetate incorporation into various lipid classes: in vivo and in vitro studies. , 2001, Indian journal of experimental biology.

[65]  G. S. Boyd,et al.  THE EFFECT OF CERTAIN THYROXINE ANALOGUES ON THE SERUM LIPIDS IN HUMAN SUBJECTS , 1960 .

[66]  Mary E. McGrath,et al.  A structural role for hormone in the thyroid hormone receptor , 1995, Nature.

[67]  B. Dozin,et al.  Identification of thyroid hormone receptors in rat liver nuclei by photoaffinity labeling with L-thyroxine and triiodo-L-thyronine. , 1985, Biochemistry.

[68]  Martin D. Brand,et al.  Body mass dependence of H+ leak in mitochondria and its relevance to metabolic rate , 1993, Nature.

[69]  H. Lardy,et al.  METABOLIC EFFECTS OF THYROXINE IN VITRO , 1951, Annals of the New York Academy of Sciences.

[70]  R. Hedman,et al.  The action of thyroid hormones at the cell level. , 1963, The Biochemical journal.

[71]  I. Chopra An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man. , 1976, The Journal of clinical investigation.

[72]  Icksoo Lee,et al.  The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. , 2004, Biochimica et biophysica acta.

[73]  Elisabetta Cerbai,et al.  The FASEB Journal • Research Communication Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function , 2022 .

[74]  J. Samarut,et al.  Thyroid hormones signaling is getting more complex: STORMs are coming. , 2007, Molecular endocrinology.

[75]  H. Beug,et al.  The c-erb-A protein is a high-affinity receptor for thyroid hormone , 1986, Nature.

[76]  J. Baxter,et al.  Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine. , 2004, Endocrinology.

[77]  M. Obregon,et al.  T3 and Triac inhibit leptin secretion and expression in brown and white rat adipocytes. , 2004, Biochimica et biophysica acta.

[78]  M. Obregon,et al.  Potent thermogenic action of triiodothyroacetic acid in brown adipocytes , 2003, Cellular and Molecular Life Sciences CMLS.

[79]  H. Samuels,et al.  Photoaffinity labeling of thyroid hormone nuclear receptors in intact cells. , 1982, The Journal of biological chemistry.

[80]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[81]  A. Lombardi,et al.  How the thyroid controls metabolism in the rat: different roles for triiodothyronine and diiodothyronines , 1997, The Journal of physiology.

[82]  Sabina Frascarelli,et al.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone , 2004, Nature Medicine.

[83]  A. Géloën,et al.  Demonstration of in vivo metabolic effects of 3,5-di-iodothyronine. , 1996, The Journal of endocrinology.

[84]  T. Visser,et al.  Identification of 3,5-diiodo-L-thyronine-binding proteins in rat liver cytosol by photoaffinity labeling. , 2003, Endocrinology.

[85]  S. B. Barker,et al.  Metabolic effects of some halogenated acrylic acid analogues of thyroxine. , 1951, Endocrinology.

[86]  K. Mahaffey,et al.  Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue. , 1995, Circulation.

[87]  S. Goldman,et al.  Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. , 1992, The Journal of pharmacology and experimental therapeutics.

[88]  K. Davey Do thyroid hormones function in insects? , 2000, Insect biochemistry and molecular biology.

[89]  R. Walsh,et al.  Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca(2+)-cycling proteins in the baboon. Implications for the force-frequency and relaxation-frequency relationships. , 1996, Circulation research.

[90]  T. Visser,et al.  Rapid glucuronidation of tri- and tetraiodothyroacetic acid to ester glucuronides in human liver and to ether glucuronides in rat liver. , 1994, Endocrinology.

[91]  H. Rokos,et al.  3,5-Di-iodo-L-thyronine suppresses TSH in rats in vivo and in rat pituitary fragments in vitro. , 1995, The Journal of endocrinology.

[92]  F. Goglia,et al.  Interaction of diiodothyronines with isolated cytochromec oxidase , 1994, FEBS letters.

[93]  J. Baxter,et al.  Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[94]  M. Hüttemann,et al.  Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. , 2000, Free radical biology & medicine.

[95]  Yida Tang,et al.  Thyroid hormone analog, diiodothyropropionic acid (DITPA), exerts beneficial effects on chamber and cellular remodeling in cardiomyopathic hamsters. , 2007, Canadian journal of physiology and pharmacology.

[96]  O. Oommen,et al.  Thyroid hormones regulate lipid peroxidation and antioxidant enzyme activities in Anabas testudineus (Bloch). , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.